Terns Pharmaceuticals Inc (TERN)
2.93 +0.01 (+0.34%) 14:35 ET [NASDAQ]
2.91 x 200 2.92 x 117
Realtime by (Cboe BZX)
2.91 x 200 2.92 x 117
Realtime 2.85 -0.07 (-2.40%) 09:28 ET
for Mon, Apr 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -88,853 | -90,210 | -60,345 | -50,158 | -40,571 |
Depreciation Amortization | 896 | 881 | 1,113 | 1,391 | 431 |
Income taxes - deferred | 23 | 141 | 392 | 219 | 693 |
Accounts payable and accrued liabilities | -367 | 1,149 | -722 | 1,727 | -1,146 |
Other Working Capital | 4,381 | 1,475 | -1,037 | -1,425 | 5,060 |
Other Operating Activity | 13,904 | 19,174 | 11,490 | 6,419 | 5,724 |
Operating Cash Flow | $-70,016 | $-67,390 | $-49,109 | $-41,827 | $-29,809 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -12,368 | -37,935 | -21,997 | -119,356 | 7,277 |
PPE Investments | -42 | -52 | -275 | -340 | -584 |
Investing Cash Flow | $-12,410 | $-37,987 | $-22,272 | $-119,696 | $6,693 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 16,876 |
Debt Issued | N/A | N/A | N/A | 149,080 | 0 |
Debt Repayment | N/A | N/A | N/A | -12,880 | 0 |
Common Stock Issued | 164,383 | 42,295 | 167,496 | 914 | 120 |
Other Financing Activity | -388 | -344 | -401 | -2,721 | 68,519 |
Financing Cash Flow | $163,995 | $41,951 | $167,095 | $134,393 | $85,515 |
Exchange Rate Effect | -56 | 117 | -178 | -25 | 80 |
Beginning Cash Position | 79,926 | 143,235 | 47,699 | 74,854 | 12,375 |
End Cash Position | 161,439 | 79,926 | 143,235 | 47,699 | 74,854 |
Net Cash Flow | $81,513 | $-63,309 | $95,536 | $-27,155 | $62,479 |
Free Cash Flow | |||||
Operating Cash Flow | -70,016 | -67,390 | -49,109 | -41,827 | -29,809 |
Capital Expenditure | -42 | -52 | -275 | -340 | -584 |
Free Cash Flow | -70,058 | -67,442 | -49,384 | -42,167 | -30,393 |